The PA Research Foundation has a proud history of funding innovative medical research at the PA Hospital Campus. From providing seed funding to the discovery of the world's first cancer vaccine, to funding a world first clinical trial in a new combination therapy for aggressive cancers such as triple negative breast cancer and head and neck cancer - we are invested in making a difference on a global scale.
Our key funded research areas are breast cancer, prostate cancer, skin cancer, other cancer and other health. Our new Research Awards which we launched in 2018 now form an intrinsic part of our fundraising efforts and help provide our valued Donors with the opportunity to have an active involvement in deciding on where their funds should be invested.
The Foundation already has an impressive track record of supporting innovation and translational research. In order to fund research that reflects and supports our vision, our funding model is based on two principles:
1. Donor Directed Approach
2. Funding of Innovative and Groundbreaking Research
The new Research Awards have been established to allow us to take a more donor directed approach in the distribution of grants; we know that our donors want to fund the most innovative and ground-breaking research leading to improved patient care in preferred areas\ our new Awards help facilitate this.
Through our new Awards, we will continue to invest in research that is innovative, novel and will give us the best opportunity of supporting the next big medical discovery or transformational health care project.
Expressions of Interest for the 2022 Research Awards are open now and close August 10.